FDA Pulmonary-Allergy Drug Advisory Committee (PADAC)

ARS Responds to FDA’s Request for Additional Study Before Approving neffy...

Dave Bloom - 2023/09/20

FDA Issues Complete Response Letter for neffy® New Drug Application with Request for Additional Study.

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

Dave Bloom - 2023/06/20

The expected approval date has been delayed from mid-year.

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

Dave Bloom - 2023/05/12

The first needle-free emergency epinephrine alternative is on the verge of FDA approval.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: FDA Pulmonary-Allergy Drug Advisory Committee (PADAC)

ARS Responds to FDA’s Request for Additional Study Before Approving neffy...

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray